Biovica International AB (OSTO:BIOVIC B) EBIT per Share : kr-2.50 (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB EBIT per Share?

Biovica International AB's EBIT per Share for the three months ended in Jan. 2024 was kr-0.44. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 was kr-2.50.

During the past 3 years, the average EBIT per Share Growth Rate was -38.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was -25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Biovica International AB's EBIT per Share or its related term are showing as below:

OSTO:BIOVIC B' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -45.3 Med: -28 Max: -12.6
Current: -38.3

During the past 9 years, the highest 3-Year average EBIT per Share Growth Rate of Biovica International AB was -12.60% per year. The lowest was -45.30% per year. And the median was -28.00% per year.

OSTO:BIOVIC B's 3-Year EBIT Growth Rate is ranked worse than
85.91% of 1299 companies
in the Biotechnology industry
Industry Median: 3.4 vs OSTO:BIOVIC B: -38.30

Biovica International AB's EBIT for the three months ended in Jan. 2024 was kr-27.42 Mil.

Biovica International AB EBIT per Share Historical Data

The historical data trend for Biovica International AB's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB EBIT per Share Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

EBIT per Share

Get a 7-Day Free Trial

-1.16

-1.22

-1.34

-2.09

-3.21

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
EBIT per Share	Get a 7-Day Free Trial															-0.63	-0.86	-0.69	-0.51	-0.44

Biovica International AB EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Biovica International AB's EBIT per Share for the fiscal year that ended in Apr. 2023 is calculated as

	EBIT per Share		(A: Apr. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-110.68	/	34.461
=	-3.21

Biovica International AB's EBIT per Share for the quarter that ended in Jan. 2024 is calculated as

	EBIT per Share		(Q: Jan. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-27.417	/	62.816
=	-0.44

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-2.50

Biovica International AB (OSTO:BIOVIC B) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Biovica International AB EBIT per Share Related Terms

Thank you for viewing the detailed overview of Biovica International AB's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines